Tamsulosine Bromo Impurity

Tamsulosine Bromo Impurity is a brominated derivative of the parent drug, featuring a bromine substitution at the 6-position of the quinazoline ring. The structure retains the sulfonamide moiety and terminal amine group characteristic of tamsulosine, with the bromo substituent introducing steric and electronic alterations. This impurity arises via electrophilic bromination during synthetic pathways, competing with the desired alkylation step. Its distinct UV absorption and chromatographic profile enable differentiation from the parent compound. Utilized as an HPLC reference standard for quantifying brominated impurities in tamsulosine active pharmaceutical ingredients.